Eculizumab as a promising rescue therapy for acute exacerbations of myasthenia gravis

Neurol Sci. 2023 Dec;44(12):4573-4574. doi: 10.1007/s10072-023-06993-5. Epub 2023 Aug 3.

Authors

Sohyeon Kim¹, Jae-Joon Lee¹, Hung Youl Seok²

Affiliations

¹ Department of Neurology, Dongsan Hospital, Keimyung University School of Medicine, 1035 Dalgubeol-daero, Dalseo-gu, Daegu, 42601, Republic of Korea.
² Department of Neurology, Dongsan Hospital, Keimyung University School of Medicine, 1035 Dalgubeol-daero, Dalseo-gu, Daegu, 42601, Republic of Korea. shy2354@gmail.com.

PMID: 37537418
DOI: 10.1007/s10072-023-06993-5

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Humans
Myasthenia Gravis* / drug therapy

Substances

eculizumab
Antibodies, Monoclonal, Humanized